ITI Pharma and Healthcare Fund Direct-Growth
Equity: Sectoral-Pharma - Growth (Open ended) Factsheet
SEBI Riskometer: Very HighCategory: Equity: Sectoral-PharmaBenchmark: NIFTY Healthcare Total Return Index.
NAV: ₹19.39+0.01%
16 Jul 2026
Loading…
| Asset | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 | 31 Mar 2026 | 28 Feb 2026 | 31 Jan 2026 |
|---|---|---|---|---|---|---|
| Equity | 96.78% | 98.01% | 98.25% | 99.18% | 98.22% | 98.24% |
| Debt | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Others (incl. cash) | 3.22% | 1.99% | 1.75% | 0.82% | 1.78% | 1.76% |
| Commodities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Real Estate | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Instrument | Sector | No. of Shares | Value (Rs. Cr) | Weight | Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | 1,80,398 | 33.6 | 13.34% | -0.91%↓ |
| Divis Laboratories Ltd. | Healthcare | 25,990 | 17.1 | 6.79% | -1.64%↓ |
| Apollo Hospitals Enterprise Ltd. | Healthcare | 18,032 | 15.66 | 6.22% | 0.02%↑ |
| Dr. Reddys Laboratories Ltd. | Healthcare | 1,00,879 | 13.69 | 5.44% | 1.46%↑ |
| Max Healthcare Institute Ltd. | Healthcare | 1,20,721 | 13.63 | 5.41% | 0.51%↑ |
| Cipla Ltd. | Healthcare | 79,036 | 11.58 | 4.60% | 1.18%↑ |
| Torrent Pharmaceuticals Ltd. | Healthcare | 24,834 | 11.47 | 4.56% | -0.34%↓ |
| Laurus Labs Ltd. | Healthcare | 73,055 | 11.09 | 4.40% | -0.66%↓ |
| Aurobindo Pharma Ltd. | Healthcare | 65,463 | 10.33 | 4.10% | -0.18%↓ |
| Lupin Ltd. | Healthcare | 34,373 | 8.31 | 3.30% | -0.23%↓ |
| Neuland Laboratories Ltd. | Healthcare | 4,185 | 7.78 | 3.09% | 0.09%↑ |
| Fortis Healthcare Ltd. | Healthcare | 77,471 | 7.41 | 2.94% | -0.08%↓ |
| Cohance Lifesciences Ltd. | Healthcare | 1,59,791 | 7.29 | 2.89% | 0.24%↑ |
| Mankind Pharma Ltd. | Healthcare | 28,118 | 7.16 | 2.84% | 0.89%↑ |
| Alkem Laboratories Ltd. | Healthcare | 12,453 | 6.94 | 2.75% | -0.13%↓ |
| Global Health Ltd. | Healthcare | 38,559 | 5.07 | 2.01% | - |
| Abbott India Ltd. | Healthcare | 1,800 | 4.58 | 1.82% | -0.21%↓ |
| Aster DM Healthcare Ltd. | Healthcare | 49,392 | 3.87 | 1.54% | -0.25%↓ |
| Ipca Laboratories Ltd. | Healthcare | 22,488 | 3.83 | 1.52% | 0.08%↑ |
| Sai Life Sciences Ltd. | Healthcare | 26,441 | 3.26 | 1.30% | -0.33%↓ |
| Sector | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 | 31 Mar 2026 | 28 Feb 2026 | 31 Jan 2026 |
|---|---|---|---|---|---|---|
| Healthcare | 92.31% | 91.57% | 92.15% | 92.34% | 91.49% | 93.39% |
| Chemicals | 1.25% | 2.42% | 2.65% | 3.66% | 3.46% | 2.54% |
| Materials | 1.22% | 1.47% | 1.29% | 1.11% | 0.99% | - |
| Metals & Mining | 0.95% | 0.81% | - | - | - | - |
| Capital Goods | 0.54% | - | 0.91% | 0.82% | 0.92% | 0.90% |
| Financial | 0.51% | 0.51% | - | - | - | - |
| Insurance | - | 1.22% | 1.26% | 1.25% | 1.36% | 1.41% |
24.6 / 100
Weighted average Value score is 24.6. This indicates that portfolio is relatively overvalued using composite of value measures.
76.0 / 100
Weighted average Price Momentum score is 76.0. This indicates that portfolio has high momentum using composite of momentum measures.
83.2 / 100
Weighted average Quality score is 83.2. This indicates that portfolio has high quality using composite of quality measures.
70.1 / 100
Weighted average QVM score is 70.1. This indicates that portfolio has average QVM score and hence a neutral stance is warranted.